Inter-firm R&D networks in pharmaceutical biotechnology : what determines firm's centrality-based partnering capability?

dc.contributor.authorSchwalbe, Ulrichde
dc.contributor.authorRiedel, Nadinede
dc.contributor.authorKrogmann, Yinde
dc.date.accessioned2024-04-08T08:48:29Z
dc.date.available2024-04-08T08:48:29Z
dc.date.created2013-06-11
dc.date.issued2013
dc.description.abstractThis paper analyses the inter-firm R&D network formed in the pharmaceutical biotechnology industry during the 1990s from different perspectives: theoretical network formation, firm's structural positions and its collaborations at the entire network level, and the determinants for firm's centrality-based partnering capability. The results indicate that pharmaceutical biotechnology industry has experienced a significant evolutional change in size and structure during 1991-1998. By considering individual structural positions, the descriptive statistics show that in the 1990s, established pharmaceutical companies developed into dominant star players with multiple partnerships while holding central roles in the R&D network. In the network analysis that emphasized aggregate network level, the degree-based and betweenness-based network centralization were not high implying that the distribution of overall positional advantages in the pharmaceutical biotechnology industry is, to a large degree, not unequal and even though most firms in this sector are linked to the R&D network, some of them are more active than others. The current analysis also shows that firm's efficiency, firm's dependency on its complementary resources and firm's experiences at managing partnerships are important determinants for firm's centrality-based partnering capability, which has important managerial implications for understanding firm's strategic partnering behaviour.en
dc.identifier.swb383453984
dc.identifier.urihttps://hohpublica.uni-hohenheim.de/handle/123456789/5712
dc.identifier.urnurn:nbn:de:bsz:100-opus-8549
dc.language.isoeng
dc.relation.ispartofseriesFZID discussion papers; 75
dc.rights.licensepubl-ohne-poden
dc.rights.licensepubl-ohne-podde
dc.rights.urihttp://opus.uni-hohenheim.de/doku/lic_ubh.php
dc.subjectInter-firm cooperationen
dc.subjectR&D partnershipsen
dc.subjectNetwork formationen
dc.subjectSocial network analysisen
dc.subjectInstrumental variableen
dc.subject.ddc330
dc.subject.gndForschung und Entwicklungde
dc.subject.gndNetzwerkde
dc.subject.gndBiotechnologiede
dc.titleInter-firm R&D networks in pharmaceutical biotechnology : what determines firm's centrality-based partnering capability?de
dc.type.dcmiTextde
dc.type.diniWorkingPaperde
local.accessuneingeschränkter Zugriffen
local.accessuneingeschränkter Zugriffde
local.bibliographicCitation.publisherPlaceUniversität Hohenheimde
local.export.bibtex@techreport{Schwalbe2013, url = {https://hohpublica.uni-hohenheim.de/handle/123456789/5712}, author = {Schwalbe, Ulrich and Riedel, Nadine and Krogmann, Yin et al.}, title = {Inter-firm R&D networks in pharmaceutical biotechnology : what determines firm's centrality-based partnering capability?}, year = {2013}, school = {Universität Hohenheim}, series = {FZID discussion papers}, }
local.export.bibtexAuthorSchwalbe, Ulrich and Riedel, Nadine and Krogmann, Yin et al.
local.export.bibtexKeySchwalbe2013
local.export.bibtexType@techreport
local.faculty.number3de
local.faculty.number7de
local.institute.number520de
local.institute.number795de
local.opus.number854
local.series.issueNumber75
local.series.titleFZID discussion papers
local.universityUniversität Hohenheimde
local.university.facultyFaculty of Business, Economics and Social Sciencesen
local.university.facultyFakultät Wirtschafts- und Sozialwissenschaftende
local.university.facultyLandesanstaltende
local.university.instituteInstitute for Economicsen
local.university.instituteInstitut für Volkswirtschaftslehrede
local.university.instituteForschungszentrum Innovation und Dienstleistungde

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
fzid_dp_2013_75_Riedel_Schwalbe.pdf
Size:
1.06 MB
Format:
Adobe Portable Document Format
Description:
Open Access Fulltext